Pharmacologic perturbation as a potential tool to increase the sensitivity of FDG-PET in the evaluation of brain tumors
Journal Article
·
· Journal of Nuclear Medicine
OSTI ID:198087
- Univ. of Texas M.D. Anderson Cancer Center, Houston, TX (United States); and others
The usefulness of F-18 FDG PET in the study of brain tumors is limited by the high baseline cortical uptake which decreases the contrast of the tumor. Two alternatives to increase the tumor/background contrast have been reported: barbiturate-induced coma and postprandial state. This project evaluates the effects of sedation with diazepam or of oral glucose intake on the brain tumor/background contrast during F-18 FDG PET studies.
- OSTI ID:
- 198087
- Report Number(s):
- CONF-940605--
- Journal Information:
- Journal of Nuclear Medicine, Journal Name: Journal of Nuclear Medicine Journal Issue: Suppl.5 Vol. 35; ISSN JNMEAQ; ISSN 0161-5505
- Country of Publication:
- United States
- Language:
- English
Similar Records
Effects of hyperglycemia on FDG-PET in patients with brain tumors
Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG study
Prediction of standard-dose brain PET image by using MRI and low-dose brain [{sup 18}F]FDG PET images
Journal Article
·
Sun May 01 00:00:00 EDT 1994
· Journal of Nuclear Medicine
·
OSTI ID:197917
Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG study
Journal Article
·
Mon May 01 00:00:00 EDT 1989
· J. Nucl. Med.; (United States)
·
OSTI ID:6028988
Prediction of standard-dose brain PET image by using MRI and low-dose brain [{sup 18}F]FDG PET images
Journal Article
·
Tue Sep 15 00:00:00 EDT 2015
· Medical Physics
·
OSTI ID:22581360